Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies by Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD

Get full text

Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies by Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM

Get full text

"BASUCO" Resumen del Foro sobre "Basuco" organizado por la Asociación Colombiana de Toxicología y Farmacodependencia by Jairo Arévalo, Jesús Idrobo, Evaristo Arévalo, Camilo Uribe, Germán Motta L., Luis Enciso

Get full text

Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer by Vancauwenberghe, E, Bolland, H, Carroll, C, Da Motta, L, Grabowska, A, Buffa, F, Harris, A, McIntyre, A

SAÚDE MENTAL X VULNERABILIDADE SOCIAL: UMA INTERVENÇÃO COM MORADORES DA TAMARINDO by SANTOS, J.C.R.F, ANDRADE, E.R, ALMEIDA, L.P, BRITO, H.P.P, CARVALHO, G.R., MOTTA, L.T.S

Get full text

Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis by Fiscone, C, Sighinolfi, G, Manners, DN, Motta, L, Venturi, G, Panzera, I, Zaccagna, F, Rundo, L, Lugaresi, A, Lodi, R, Tonon, C, Castelli, M

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC) by Harris, A, da Motta, L, Ledaki, I, Purshouse, K, Haider, S, De Bastiani, M, Babin, D, Morotti, M, Steers, G, Wigfield, S, Bridges, E, Knapp, S, Ebner, D, Klimt, F, McIntyre, A

Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth–seventh century BC, central Italy) by Bagnasco, G, Marzullo, M, Cattaneo, C, Biehler-Gomez, L, Mazzarelli, D, Ricciardi, V, Müller, W, Coppa, A, McLaughlin, R, Motta, L, Prato, O, Schmidt, F, Gaveriaux, F, Marras, GB, Millet, MA, Madgwick, R, Ballantyne, R, Makarewicz, C, Trentacoste, A, Reimer, P, Mattiangeli, V, Bradley, DG, Malone, C, Esposito, C

Integrating metabolomics, genomics and disease pathways in age-related macular degeneration: The EYE-RISK Consortium by Acar, IE, Lores-Motta, L, Colijn, JM, Meester-Smoor, MA, Verzijden, T, Cougnard-Gregoire, A, Ajana, S, Merle, BMJ, de Breuk, A, Heesterbeek, TJ, van den Akker, E, Daha, MR, Claes, B, Pauleikhoff, D, Hense, H-W, van Duijn, CM, Fauser, S, Hoyng, CB, Delcourt, C, Klaver, CCW, Galesloot, TE, den Hollander, AI, EYE-RISK Consortium